Toll-like receptor 3 (TLR3) was shown to play a dual role in ovarian cancer by eliminating tumor cells via upregulation of interferons and activation of natural killer cells and also by promoting cancer development (Husseinzadeh and Davenport, 2014). Here, TLR3 is linked to cancer.